With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
Health financing and payment, results-based financing, social protection, conditional cash transfer programs, noncommunicable disease, maternal and child health
Amanda Glassman is chief operating officer and senior fellow at the Center for Global Development and also serves as secretary of the board. Her research focuses on priority-setting, resource allocation and value for money in global health, as well as data for development. Prior to her current position, she served as director for global health policy at the Center from 2010 to 2016, and has more than 25 years of experience working on health and social protection policy and programs in Latin America and elsewhere in the developing world.
Prior to joining CGD, Glassman was principal technical lead for health at the Inter-American Development Bank, where she led policy dialogue with member countries, designed the results-based grant program Salud Mesoamerica 2015 and served as team leader for conditional cash transfer programs such as Mexico’s Oportunidades and Colombia’s Familias en Accion. From 2005-2007, Glassman was deputy director of the Global Health Financing Initiative at Brookings and carried out policy research on aid effectiveness and domestic financing issues in the health sector in low-income countries. Before joining the Brookings Institution, Glassman designed, supervised and evaluated health and social protection loans at the Inter-American Development Bank and worked as a Population Reference Bureau Fellow at the US Agency for International Development. Glassman holds a MSc from the Harvard School of Public Health and a BA from Brown University, has published on a wide range of health and social protection finance and policy topics, and is editor and coauthor of the books Millions Saved: New Cases of Proven Success in Global Health (Center for Global Development 2016), From Few to Many: A Decade of Health Insurance Expansion in Colombia (IDB and Brookings 2010), and The Health of Women in Latin America and the Caribbean (World Bank 2001).
Earlier this month, the first analysis of countries’ progress towards attaining the health-related Sustainable Development Goals (SDGs) was published in the Lancet. The Institute for Health Metrics and Evaluation (IHME) used Global Burden of Disease Data (GBD 2016) to create an index for 37 (out of 50) health-related SDG indicators between 1990–2016, for a total of 188 countries. Based on the pace of change recorded over the past 25 years or so, the researchers then projected the indicators to 2030. The punchline: if past is prologue, the median number of SDG targets attained in 2030 will be five of the 24 defined targets currently measured. Not very inspiring.
In recent years, there has been tremendous progress in improving the treatment and prevention of diseases, resulting in millions of lives saved around the world. While some of this progress is due to economic growth, aid from several bilateral, multilateral, and philanthropic donors has made important contributions to reducing the global burden of disease. In this seminar, Alec Morton will present new research focusing on decision rules to guide how donors should allocate aid money given that resources are limited.
Global health policy enthusiasts will be excited to see that WHO has recently published a draft Concept Note on the 2019-2023 Programme of Work under the stewardship of its new Director-General. We see two glaring missed opportunities: 1) more centrality to universal health coverage (UHC) as an organizing principle for WHO and its work, and 2) more emphasis on enhancing the value for money of public spending on UHC and elsewhere.
Clear and rigorous evidence on the contributions of US global health programs is more important than ever, as the White House and lawmakers discuss and debate budgets and the future of US support to global health. Such information aids policymakers who must prioritize support to effective public health programs.
This event will serve as an opportunity to discuss and celebrate the launch of a special supplement to the American Journal of Tropical Medicine and Hygiene that reports on nine new contributions on the impact of malaria control interventions. Specifically, the articles document the success of various malaria control efforts (including the causal link between malaria intervention scale-up and reductions in malaria morbidity and mortality) and new methods for evaluating the impact of large-scale malaria control programs. Taken together, the articles represent a conceptual and practical framework for planning and executing a new generation of impact evaluations, with possible applications to other health conditions in low-resource settings.
In this paper, the authors discuss the rationale for
investing in vaccination and construct a
metric to measure country commitment
to vaccination that would promote
accountability and better tracking of
Over 1 billion women lack access to financial services due to economic and social barriers, time and mobility constraints, and discrimination in service provision. Financial services delivered digitally can address these barriers by providing women with safe and accessible channels. This event will look at the recent evidence and emerging technologies that work to empower women economically.
The Institute for Health Metrics and Evaluation's Financing Global Health 2012: The End of the Golden Age? report shows that after two decades of sustained, rapid growth, development assistance for health (DAH) has flat-lined. DAH peaked at a record high in 2010 and has not grown since. This plateau raises a number of new considerations for priority-setting and international health targets in the post-MDG era. Christopher Murray and Michael Hanlon will address implications of these financing trends for global health donors and recipient countries, as well as the potential for this work to inform how available funding can be better used to improve population health.
The authors carry out a systematic review of studies on CCTs that report maternal and newborn health outcomes, including studies from eight countries. We find that CCTs have increased antenatal visits, skilled attendance at birth, delivery at a health facility, and tetanus toxoid vaccination for mothers, and reduced the incidence of low birth weight. The programs have not had a significant impact on fertility or Caesarean sections while impact on maternal and newborn mortality has not been well documented thus far.
The Economist’s take on the Give Directly evaluation argues that unconditional cash transfers (UCT) “don’t deal with the deeper causes of poverty.” The article cites Baird and co-authors’ review showing that vigorously enforced conditional cash transfer (CCT) programs generate larger effects on school enrollment than UCT, and suggests that CCT are thus better positioned to address the root causes of poverty.